ACHAIKI IATRIKI | 2025; 44(2): 66
Letter from the editor
Dear colleagues,
In the current issue, the editorial by Pastras et al. highlights recent advances in the understanding, diagnosis, and treatment of Autoimmune Pancreatitis (AIP). The article particularly emphasizes on emerging therapeutic strategies and the shift toward pathophysiology-driven, personalized care.
The current issue features four review articles. The first, authored by Kyriazoglou et al., discusses recent advances in the management of soft tissue sarcomas, focusing on the integration of neoadjuvant therapies, immunotherapy, and precision medicine strategies to improve patient outcomes. The review by Filippopoulou et al. examines the key factors contributing to difficult-to-treat rheumatoid arthritis and highlights the critical role of early identification in enhancing disease management and improving patient outcomes. The review by Chardalia et al. underscores the clinical importance of early diagnosis of immune checkpoint inhibitor-induced colitis emphasizing management strategies aligned with the latest evidence-based guidelines, while also exploring emerging therapeutic approaches. Finally, the review by Kyriakopoulos et al. studies the significance of immune checkpoint inhibitor-induced thyroid dysfunction, highlighting its clinical patterns, underlying mechanisms, diagnostic methods, and management strategies.
Lastly, this issue features a case report by Ndidiamaka Onyiriuka Daniel, which discusses the psychosocial impact of childhood vitiligo on both the patient and her family. It emphasizes the importance of addressing the concerns of parents and reviews the recommended treatment guidelines for childhood vitiligo, along with certain challenges associated with their application.
Yours sincerely,
C Triantos
Associate Professor in Internal Medicine
and Gastroenterology Faculty of Medicine,
School of Health Sciences, University of Patras
Editor-in-Chief of the journal “ACHAIKI IATRIKI”